Mary Margaret Gozar

Summary

Affiliation: Johnson and Johnson Pharmaceutical Research and Development
Country: USA

Publications

  1. ncbi Dz13, a DNAzyme targeting c-jun, induces off-target cytotoxicity in endothelial cells with features of nonapoptotic programmed cell death
    Mary Margaret Gozar
    Johnson and Johnson Research Pty Limited, Eveleigh, New South Wales, 1430, Australia
    Oligonucleotides 18:257-68. 2008
  2. ncbi The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity
    Laurent Rivory
    Johnson and Johnson Research Pty, Ltd, Eveleigh, NSW, 1430, Australia
    Oligonucleotides 16:297-312. 2006
  3. ncbi Cytotoxic G-rich oligodeoxynucleotides: putative protein targets and required sequence motif
    Amber Goodchild
    Johnson and Johnson Research Pty Ltd, Eveleigh, NSW, 1430, Australia
    Nucleic Acids Res 35:4562-72. 2007

Detail Information

Publications3

  1. ncbi Dz13, a DNAzyme targeting c-jun, induces off-target cytotoxicity in endothelial cells with features of nonapoptotic programmed cell death
    Mary Margaret Gozar
    Johnson and Johnson Research Pty Limited, Eveleigh, New South Wales, 1430, Australia
    Oligonucleotides 18:257-68. 2008
    ....
  2. ncbi The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity
    Laurent Rivory
    Johnson and Johnson Research Pty, Ltd, Eveleigh, NSW, 1430, Australia
    Oligonucleotides 16:297-312. 2006
    ..These data reveal that the biologic activity of several published DNAzymes is not mediated through the catalytic degradation of target mRNA...
  3. ncbi Cytotoxic G-rich oligodeoxynucleotides: putative protein targets and required sequence motif
    Amber Goodchild
    Johnson and Johnson Research Pty Ltd, Eveleigh, NSW, 1430, Australia
    Nucleic Acids Res 35:4562-72. 2007
    ....